Weight loss timelines vary based on starting weight, dose, diet, and activity level
Patients appreciate clear education, ongoing monitoring, and a supportive environment where weight management is treated as part of overall well-beingnot a one-size-fits-all program
Naunyn Schmiedebergs ArchPharmacol
The patient has shown a reduction in BMI from baseline or has maintained the BMI reduction
Additional objectives included describing specific problems with taking GLP1 RAs reported by patients and perceived by physicians, ranking and assessing how much these problems affected patients, and understanding whether physicians perceptions reflected patients experiences
Mechanism of Action NA-931s design leverages the complementary actions of four different hormone pathways that regulate metabolism